Repositive and Algorithm 379 Presents: Artificial Intelligence in Drug Discovery and Development

By Repositive

There is a growing trend of leveraging the use of artificial intelligence (AI) in drug discovery and development. This includes usage of AI in target identification, lead optimization, selection of preclinical cancer models and patient population for clinical trials and many other milestones of the drug development process.

To read more, please download our free e-book.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.